Avertix Medical

Avertix Medical company information, Employees & Contact Information

Explore related pages

Related company profiles:

Avertix is committed to advancing life-sustaining patient care and the long-term management of Advanced Cardiovascular Disease through innovation, clinical science, and collaboration. With FDA-approved labeling indicating the Guardian System is safe and effective, we’re dedicated to providing physicians, health systems, and allied health professionals with the Avertix Guardian to help advance the standard of patient care. Avertix’s Guardian™ is the first implantable, patient alerting system designed to warn patients to seek medical attention for Acute Coronary Syndrome (ACS), including silent heart attacks. Delays in treatment contribute to the high level of mortality and morbidity from heart attacks. Symptoms (such as chest pain) are a poor predictor of ACS events with less than 20% of patients presenting to the emergency room actually having a true positive ACS event and more than one-third of heart attacks having atypical or no symptoms.

Company Details

Employees
49
Founded
-
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
Keywords
Engineer jobs.
Looking for a particular Avertix Medical employee's phone or email?

Avertix Medical Questions

News

Avertix's Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients - PR Newswire

Avertix's Guardian System Confirmed as Cost-Effective for High-Risk Acute Coronary Syndrome Patients PR Newswire

Avertix Medical Bolsters Board of Directors with Key Additions - PR Newswire

Avertix Medical Bolsters Board of Directors with Key Additions PR Newswire

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation - Diagnostic and Interventional Cardiology

Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation Diagnostic and Interventional Cardiology

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination - GlobeNewswire

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination GlobeNewswire

Avertix Medical to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference - PR Newswire

Avertix Medical to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference PR Newswire

Angel Medical Systems, Creator of the Guardian™, First - GlobeNewswire

Angel Medical Systems, Creator of the Guardian™, First GlobeNewswire

AVERTIX MEDICAL ANNOUNCES FAVORABLE CHANGES TO CMS REIMBURSEMENT FOR THE GUARDIAN IN 2025 - PR Newswire

AVERTIX MEDICAL ANNOUNCES FAVORABLE CHANGES TO CMS REIMBURSEMENT FOR THE GUARDIAN IN 2025 PR Newswire

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors - Yahoo Finance

Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors Yahoo Finance

Top Avertix Medical Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant